Breast Cancer Trial, Recruiting NCT07165756 Sponsor: Institut de Cancérologie de Lorraine Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07165756
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have breast cancer that has not spread beyond the breast or nearby area (localized breast cancer) and are being seen for drug treatment such as chemotherapy, immunotherapy, or targeted therapy.
  • You have been diagnosed with invasive breast cancer that requires both local treatment (such as surgery or radiotherapy) and medical/drug treatment.
  • You are in generally good or fully active health, with little to no limitation in daily activities (confirm with trial site).
  • You have read, understood, and signed the consent form for the trial.
  • You are registered with the French social security system.

Who may not be able to join:

  • Your breast cancer has spread to other parts of the body (metastatic breast cancer).
  • You have a history of another type of cancer.
  • You are unable to read or speak French.
  • You are currently under legal guardianship, curatorship, or are deprived of your liberty.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institut de Cancérologie de Lorraine
Registry
ClinicalTrials.gov
Start date
9 September 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Acceptability rate; Variation in the anxiety score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov